Swedish Orphan Biovitrum AB (publ) (BIOVF)
Swedish Orphan Biovitrum AB (publ), a biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
$48.21+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+61.8%
The outlook
Swedish Orphan Biovitrum AB (publ) currently reads as bullish based on above its 50- & 200-day averages, 96% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range96% of the way from its 52-week low to high
Market cap
$16.81B
52-wk high
$49.03
52-wk low
$28.94
50-day avg
$48.16
200-day avg
$40.49
Trailing P/E
120.5